Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Milestone Pharmaceuticals Inc (NASDAQ: MIST) was $1.59 for the day, up 4.61% from the previous closing price of $1.52. In other words, the price has increased by $4.61 from its previous closing price. On the day, 0.54 million shares were traded.
Ratios:
Our analysis of MIST’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.67 and its Current Ratio is at 4.67.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $9.
On June 20, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $4.
Piper Sandler Upgraded its Neutral to Overweight on April 22, 2022, whereas the target price for the stock was revised from $8 to $10.
Stock Price History:
Over the past 52 weeks, MIST has reached a high of $2.75, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is 28.99%, while the 200-Day Moving Average is calculated to be -2.54%.
Shares Statistics:
A total of 53.46M shares are outstanding, with a floating share count of 52.90M. Insiders hold about 1.06% of the company’s shares, while institutions hold 22.24% stake in the company.
